Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day everyone and welcome to today's Catalyst Pharmaceuticals first quarter 2025 financial results conference call. At this time all participants are in a listen only mode. Later you will have an opportunity to ask questions during the question and answer session. You may register to ask a question at any time by pressing the star and one keys on your telephone keypad. Please note this call is being recorded and that I will be standing by should you need any assistance. It is now my pleasure to turn today's program over to Mike Kalb, CFO. Please begin. Good morning, everyone, and thank you for joining our conference call to discuss Catalyst's first quarter 2025 financial results and business highlights. Leading the call today is Richard Daley, Catalyst's president and chief executive officer. We are also joined by Jeff Del Carmen, our chief commercial officer. Further, for the Q&A session, Dr. Steve Miller, our Chief Operating Officer and Chief Scientific Officer, will be available for questions. Before we begin, I would like to remind you that in our remarks this morning and in the Q&A session, we will make statements about expected future results, which may be forward-looking statements for purposes of federal securities laws. These statements relate to our current expectations, estimates and projections, and are not guarantees of future performance. They involve risks, uncertainties and assumptions that are difficult to predict and may not prove to be accurate. Actual results may vary from the expectations contained in our forward-looking statements. These forward-looking statements should be considered only in conjunction with the detailed information contained in our SEC filings, including the risk factors described in our recent 2024 annual report on Form 1...